Funding news
Modra Pharmaceuticals logo

Modra Pharmaceuticals Raises $100K Funding

Recently funded · $100.0K UnknownHospitals and Health CareView source

Get the full Modra Pharmaceuticals company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Modra Pharmaceuticals, a clinical stage company focused on enabling oral bioavailability for existing anticancer drugs, has secured $100K in new capital. The Amsterdam-based spin-out from the Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis (NKI-AVL) and MC Slotervaart aims to improve cancer therapy and supportive care through its "iv to oral switch" paradigm. Modra's pipeline includes several products in preclinical and clinical development, notably oral formulations of docetaxel and paclitaxel.

Other recently funded companies

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Unknown rounds

Companies that recently closed a Unknown round.

#CompanyAmount
1
KaMin logo

KaMin

United States

$100.0K
2
Mercer Medicine logo

Mercer Medicine

United States

$100.0K
3
Sellers Construction Company logo

Sellers Construction Company

United States

$100.0K
4
Cherokee Brick logo

Cherokee Brick

United States

$100.0K
5
Brick Industry Association logo

Brick Industry Association

United States

$100.0K